{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:15:18Z","timestamp":1707524118972},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,6,18]]},"DOI":"10.7759\/cureus.40611","type":"journal-article","created":{"date-parts":[[2023,6,19]],"date-time":"2023-06-19T05:21:56Z","timestamp":1687152116000},"source":"Crossref","is-referenced-by-count":0,"title":["Co-occurrence of Anti-GAD65 Syndrome, Type 1 Diabetes Mellitus, and Focal Seizures With Impaired Awareness"],"prefix":"10.7759","author":[{"given":"Kieu-Tram","family":"Bach","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shahini","family":"Ananth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ikjot","family":"Thind","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Forshing","family":"Lui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1993.tb03165.x","article-title":"Regulation of gamma-aminobutyric acid synthesis in the brain","volume":"60","author":"Martin DL","year":"1993","unstructured":"Martin DL, Rimvall K. Regulation of gamma-aminobutyric acid synthesis in the brain. J Neurochem. 1993, 60:395-407. 10.1111\/j.1471-4159.1993.tb03165.x","journal-title":"J Neurochem"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/0896-6273(91)90077-d","article-title":"Two genes encode distinct glutamate decarboxylases","volume":"7","author":"Erlander MG","year":"1991","unstructured":"Erlander MG, Tillakaratne NJ, Feldblum S, Patel N, Tobin AJ. Two genes encode distinct glutamate decarboxylases. Neuron. 1991, 7:91-100. 10.1016\/0896-6273(91)90077-d","journal-title":"Neuron"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-4159.1991.tb08211.x","article-title":"Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions","volume":"56","author":"Kaufman DL","year":"1991","unstructured":"Kaufman DL, Houser CR, Tobin AJ. Two forms of the gamma-aminobutyric acid synthetic enzyme glutamate decarboxylase have distinct intraneuronal distributions and cofactor interactions. J Neurochem. 1991, 56:720-3. 10.1111\/j.1471-4159.1991.tb08211.x","journal-title":"J Neurochem"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000696","article-title":"Neurologic syndromes related to anti-GAD65: clinical and serologic response to treatment","volume":"7","author":"Mu\u00f1oz-Lopetegi A","year":"2020","unstructured":"Mu\u00f1oz-Lopetegi A, de Bruijn MA, Boukhrissi S, et al.. Neurologic syndromes related to anti-GAD65: clinical and serologic response to treatment. Neurol Neuroimmunol Neuroinflamm. 2020, 7:10.1212\/NXI.0000000000000696","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21103701","article-title":"Neurological syndromes associated with anti-GAD antibodies","volume":"21","author":"Dade M","year":"2020","unstructured":"Dade M, Berzero G, Izquierdo C, et al.. Neurological syndromes associated with anti-GAD antibodies. Int J Mol Sci. 2020, 21:10.3390\/ijms21103701","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00579","article-title":"Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs","volume":"9","author":"M\u00e4kel\u00e4 KM","year":"2018","unstructured":"M\u00e4kel\u00e4 KM, Hietaharju A, Brander A, Peltola J. Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs. Front Neurol. 2018, 9:579. 10.3389\/fneur.2018.00579","journal-title":"Front Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.31486\/toj.20.0096","article-title":"Treatment of anti-GAD65 autoimmune encephalitis with methylprednisolone","volume":"21","author":"Azizi S","year":"2021","unstructured":"Azizi S, Vadlamuri DL, Cannizzaro LA. Treatment of anti-GAD65 autoimmune encephalitis with methylprednisolone. Ochsner J. 2021, 21:312-5. 10.31486\/toj.20.0096","journal-title":"Ochsner J"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s13311-022-01188-w","article-title":"Stiff-person syndrome and GAD antibody-spectrum disorders: GABAergic neuronal excitability, immunopathogenesis and update on antibody therapies","volume":"19","author":"Dalakas MC","year":"2022","unstructured":"Dalakas MC. Stiff-person syndrome and GAD antibody-spectrum disorders: GABAergic neuronal excitability, immunopathogenesis and update on antibody therapies. Neurotherapeutics. 2022, 19:832-47. 10.1007\/s13311-022-01188-w","journal-title":"Neurotherapeutics"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1001\/jamaneurol.2016.0133","article-title":"Clinical and immunologic investigations in patients with stiff-person spectrum disorder","volume":"73","author":"Martinez-Hernandez E","year":"2016","unstructured":"Martinez-Hernandez E, Ari\u00f1o H, McKeon A, et al.. Clinical and immunologic investigations in patients with stiff-person spectrum disorder. JAMA Neurol. 2016, 73:714-20. 10.1001\/jamaneurol.2016.0133","journal-title":"JAMA Neurol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.11995","article-title":"Stiff-person syndrome: a treatment update and new directions","volume":"12","author":"Ortiz JF","year":"2020","unstructured":"Ortiz JF, Ghani MR, Morillo Cox \u00c1, Tambo W, Bashir F, Wirth M, Moya G. Stiff-person syndrome: a treatment update and new directions. Cureus. 2020, 12:e11995. 10.7759\/cureus.11995","journal-title":"Cureus"},{"key":"ref11","article-title":"Stiff person syndrome","author":"Muranova A","year":"2023","unstructured":"Muranova A, Shanina E. Stiff person syndrome. StatPearls [Internet]. StatPearls Publishing, Treasure Island; 2023 Jan-."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.0903728","article-title":"Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells","volume":"184","author":"Burton AR","year":"2010","unstructured":"Burton AR, Baquet Z, Eisenbarth GS, Tisch R, Smeyne R, Workman CJ, Vignali DA. Central nervous system destruction mediated by glutamic acid decarboxylase-specific CD4+ T cells. J Immunol. 2010, 184:4863-70. 10.4049\/jimmunol.0903728","journal-title":"J Immunol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jneuroim.2022.577915","article-title":"Stiff person syndrome spectrum disorders; more than meets the eye","volume":"369","author":"Newsome SD","year":"2022","unstructured":"Newsome SD, Johnson T. Stiff person syndrome spectrum disorders; more than meets the eye. J Neuroimmunol. 2022, 369:577915. 10.1016\/j.jneuroim.2022.577915","journal-title":"J Neuroimmunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1186\/s12883-018-1232-z","article-title":"Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder","volume":"19","author":"Rakocevic G","year":"2019","unstructured":"Rakocevic G, Alexopoulos H, Dalakas MC. Quantitative clinical and autoimmune assessments in stiff person syndrome: evidence for a progressive disorder. BMC Neurol. 2019, 19:1. 10.1186\/s12883-018-1232-z","journal-title":"BMC Neurol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2020-325275","article-title":"Clinical spectrum of high-titre GAD65 antibodies","volume":"92","author":"Budhram A","year":"2021","unstructured":"Budhram A, Sechi E, Flanagan EP, et al.. Clinical spectrum of high-titre GAD65 antibodies. J Neurol Neurosurg Psychiatry. 2021, 92:645-54. 10.1136\/jnnp-2020-325275","journal-title":"J Neurol Neurosurg Psychiatry"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/159653-co-occurrence-of-anti-gad65-syndrome-type-1-diabetes-mellitus-and-focal-seizures-with-impaired-awareness","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:51:21Z","timestamp":1707508281000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/159653-co-occurrence-of-anti-gad65-syndrome-type-1-diabetes-mellitus-and-focal-seizures-with-impaired-awareness"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6,18]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.40611","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,6,18]]}}}